Clinical Trial Update: Safety and Efficacy of Oral Deferasirox in Patients With Porphyria Cutanea Tarda [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial is evaluating the safety and efficacy of oral deferasirox in patients with porphyria cutanea tarda.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Porphyria Cutanea Tarda

Drugs mentioned

• Deferasirox (Deferasirox)

Snippet

Sponsor: Assistance Publique - Hôpitaux de Paris | Conditions: Porphyria Cutanea Tarda | Phase 2 | Status: UNKNOWN